Curemark Competitors and Similar CompaniesClear all
Curemark's competitors and similar companies include Incendia Therapeutics.
 Curemark Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders. |  Incendia Therapeutics Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment. | |
Founding Date | Founding Date 2006 | Founding Date 2019 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Rye, US HQ Rye Brook, US | Locations Boston, US HQ |
Employees | Employees 23 | Employees 41 |
Funding | ||
Latest funding round | Latest funding round $ 5.4m (almost 7 years ago) | Latest funding round $ 65m (over 4 years ago) |
Total funding raised | Total funding raised $ 55.7m | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
Incendia Therapeutics
HQ
Boston, US
Employees
41
Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment.
View company